|
Online Database of Chemicals from Around the World | Search | Submit | Advertise |
Home >> Chemical Listing >> Edoxaban hydrochloride>> Market Analysis Reports |
Market Analysis Reports of Edoxaban hydrochloride |
|
CAS 480448-29-1 Edoxaban hydrochloride Chemical Report & Database CAS 480448-29-1 Edoxaban hydrochloride Chemical Report & Database This Edoxaban hydrochloride Chemical World ... . The Edoxaban hydrochloride World Consumption Report & Database definitions: Name: Edoxaban hydrochloride: Edoxaban-hydrochloride; N1-(5-Chloro ... Atrial Fibrillation Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update Atrial Fibrillation Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Atrial Fibrillation - Drugs in Development by ... SymBio pharma - TREAKISYM’s Label Expansion + Rigosertib’s Potential in MDS market + Cash to In-license More! SymBio (4582) licensed Onconova’s Rigosertib (SyB L-1101, PhI, RRMDS, Dual inhibitor of PI-3 and PL-1 Kinase Inhibitor) and gained Japan/Korea rights in 2011. Onconova Therapeutics (ONTX) debut in NASDAQ has been very encouraging and should percolate into ... |